180 related articles for article (PubMed ID: 16787095)
1. Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions.
Kawatkar SP; Kuntz DA; Woods RJ; Rose DR; Boons GJ
J Am Chem Soc; 2006 Jun; 128(25):8310-9. PubMed ID: 16787095
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of inhibition of Golgi alpha-mannosidase II by mannostatin A.
Kuntz DA; Zhong W; Guo J; Rose DR; Boons GJ
Chembiochem; 2009 Jan; 10(2):268-77. PubMed ID: 19101978
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Golgi mannosidase II with mannostatin A analogues: synthesis, biological evaluation, and structure-activity relationship studies.
Li B; Kawatkar SP; George S; Strachan H; Woods RJ; Siriwardena A; Moremen KW; Boons GJ
Chembiochem; 2004 Sep; 5(9):1220-7. PubMed ID: 15368573
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling studies of "flap up" mannosyl cation mimics.
Winkler DA
J Med Chem; 1996 Oct; 39(21):4332-4. PubMed ID: 8863810
[TBL] [Abstract][Full Text] [Related]
5. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
[TBL] [Abstract][Full Text] [Related]
6. Mannostatin A, a new glycoprotein-processing inhibitor.
Tropea JE; Kaushal GP; Pastuszak I; Mitchell M; Aoyagi T; Molyneux RJ; Elbein AD
Biochemistry; 1990 Oct; 29(43):10062-9. PubMed ID: 2271638
[TBL] [Abstract][Full Text] [Related]
7. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms.
Shah N; Kuntz DA; Rose DR
Biochemistry; 2003 Dec; 42(47):13812-6. PubMed ID: 14636047
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen.
Kuntz DA; Tarling CA; Withers SG; Rose DR
Biochemistry; 2008 Sep; 47(38):10058-68. PubMed ID: 18759458
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
Englebienne P; Fiaux H; Kuntz DA; Corbeil CR; Gerber-Lemaire S; Rose DR; Moitessier N
Proteins; 2007 Oct; 69(1):160-76. PubMed ID: 17557336
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a potent aminocyclitol alpha-mannosidase inhibitor, 1L-(1,2,3,5/4)-5-amino-4-O-methyl-1,2,3,4-cyclopentanetetrol.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 2000 May; 10(10):1047-50. PubMed ID: 10843213
[TBL] [Abstract][Full Text] [Related]
11. Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant.
Zhong W; Kuntz DA; Ember B; Singh H; Moremen KW; Rose DR; Boons GJ
J Am Chem Soc; 2008 Jul; 130(28):8975-83. PubMed ID: 18558690
[TBL] [Abstract][Full Text] [Related]
12. Binding of sulfonium-ion analogues of di-epi-swainsonine and 8-epi-lentiginosine to Drosophila Golgi alpha-mannosidase II: the role of water in inhibitor binding.
Kumar NS; Kuntz DA; Wen X; Pinto BM; Rose DR
Proteins; 2008 May; 71(3):1484-96. PubMed ID: 18076078
[TBL] [Abstract][Full Text] [Related]
13. Human lysosomal alpha-mannosidases exhibit different inhibition and metal binding properties.
Venkatesan M; Kuntz DA; Rose DR
Protein Sci; 2009 Nov; 18(11):2242-51. PubMed ID: 19722277
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor cell invasion in the Boyden chamber assay by a mannosidase inhibitor, mannostatin A.
Ochi Y; Atsumi S; Aoyagi T; Umezawa K
Anticancer Res; 1993; 13(5A):1421-4. PubMed ID: 8239514
[TBL] [Abstract][Full Text] [Related]
15. Cyclopentanes from N-amino-glyconolactams. A synthesis of mannostatin A.
Hu G; Zimmermann M; Ramana CV; Vasella A
Chem Commun (Camb); 2003 Apr; (8):952-3. PubMed ID: 12744315
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of the glycosylation step catalyzed by Golgi alpha-mannosidase II: a QM/MM metadynamics investigation.
Petersen L; Ardèvol A; Rovira C; Reilly PJ
J Am Chem Soc; 2010 Jun; 132(24):8291-300. PubMed ID: 20504027
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of alpha-mannosidase inhibitory activity of three deoxy derivatives of mannostatin A.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 1999 Jun; 9(11):1499-504. PubMed ID: 10386924
[TBL] [Abstract][Full Text] [Related]
18. Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site.
Shah N; Kuntz DA; Rose DR
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9570-5. PubMed ID: 18599462
[TBL] [Abstract][Full Text] [Related]
19. Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells.
van den Elsen JM; Kuntz DA; Rose DR
EMBO J; 2001 Jun; 20(12):3008-17. PubMed ID: 11406577
[TBL] [Abstract][Full Text] [Related]
20. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
